BiotechTube

Norgestimate; Ethinyl Estradiol; Folic acid

Phase 1Completed
1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Interactions

Conditions

Drug Interactions, Contraception, Pharmacokinetics

Trial Timeline

Jan 1, 2005 → Feb 1, 2005

NCT ID
NCT00709332

About Norgestimate; Ethinyl Estradiol; Folic acid

Norgestimate; Ethinyl Estradiol; Folic acid is a phase 1 stage product being developed by Johnson & Johnson for Drug Interactions. The current trial status is completed. This product is registered under clinical trial identifier NCT00709332. Target conditions include Drug Interactions, Contraception, Pharmacokinetics.

What happened to similar drugs?

8 of 15 similar drugs in Drug Interactions were approved

Approved (8) Terminated (3) Active (5)
✅CefiderocolShionogiApproved
✅OnabotulinumtoxinA 145 UNT [Botox]AbbVieApproved
✅Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mLNovartisApproved
✅Oseltamivir + WarfarinRocheApproved
✅Rivaroxaban 20mg + Sotorasib 960mgAmgenApproved
✅Polyene phosphatidylcholine injection 930 mg QD + Magnesium Isoglycyrrhizinate injection 200 mg QDHaisco Pharmaceutical GroupApproved
✅AZILECT® + PlaceboLundbeckApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00709982Phase 1Completed
NCT00709332Phase 1Completed

Competing Products

20 competing products in Drug Interactions

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
32
GP404141 + NplateGEROPHARMPhase 3
34
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
29
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
29
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
29
DS-1040b + ClopidogrelDaiichi SankyoPhase 1
29
EC905 + verapamilAstellas PharmaPhase 1
29
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
29
enzalutamide + rifampinAstellas PharmaPhase 1
29
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
29
CefiderocolShionogiApproved
50
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
29
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
29
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
29
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
40
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
29
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
29
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit JuiceJohnson & JohnsonPhase 1
29
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
40
Pyrotinib Maleate + EfavirenzJiangsu Hengrui MedicinePhase 1
25